Vertex Innovations, Inc. company information, Employees & Contact Information

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week Business Wire

(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain Vertex Pharmaceuticals Newsroom

Vertex Inc. Reports Significant Increase in 2025 Mid-Year U.S. Sales Tax Rate Changes Quiver Quantitative

Vertex Pharmaceuticals (VRTX) Reports Strong Q2 2025 Revenue Growth with US$2,965 Million Yahoo Finance

Vertex at Bank of America Conference: Strategic Drug Developments Investing.com

US FDA approves Vertex's non-opioid painkiller Reuters

What Is Journavx, the New Opioid-Free Painkiller from Vertex? Scientific American

Indian American biotech firms Vertex, CRISPR Therapeutics named among most influential companies Diya TV

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd Business Wire

Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout statnews.com

FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades CNBC

Vertex: New non-opioid painkiller Journavx approved by US FDA BBC

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis BioSpace

US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment Reuters

Home Vertex Pharmaceuticals

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions Business Wire

CMS enters agreement with Vertex, bluebird to improve access to gene therapies Reuters

Our Science | Partner with Us Vertex Pharmaceuticals

Our Locations Vertex Pharmaceuticals

CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround Fierce Pharma

A new, non-opioid pain drug is here. Getting it to patients could be agony. BioPharma Dive

Vertex Expands e-Invoicing Capabilities to Streamline Compliance & Reporting GlobeNewswire

Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia Fierce Pharma

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK Business Wire

Vertex Announces Key Advancements Across Kidney Portfolio Business Wire

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche Yahoo Finance

Vertex sues US over limits on providing fertility services to Casgevy patients BioPharma Dive

Canada Approves Vertex and CRISPR Therapeutics’ Gene Therapy Casgevy for Sickle Cell Disease and TDT CGTLive®

Vertex Joins Oracle’s Enhanced PartnerNetwork Program GlobeNewswire

Vertex Solutions Earns Contract to Provide Immersive Training to Air Force FLYING Magazine

Vertex sues US for right to provide fertility assistance program to gene therapy patients Fierce Pharma

Vertex sues U.S. government over access to fertility support services for Casgevy patients statnews.com

TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals Time Magazine

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants Yahoo Finance

Vertex given green light to seek US approval of CRISPR-based therapy BioPharma Dive

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Business Wire

Vertex Sues US Government Over Fertility Services for Casgevy Treatment BioSpace

Vertex begins bid for US approval of non-opioid painkiller BioPharma Dive

Vertex sues US over fertility support program for Casgevy gene editing therapy Reuters

Vertex Ventures US Raises $200 Million Third Fund to Double-down on high-conviction approach to venture capital Business Wire

FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study Reuters

US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder Reuters

U.S. Air Force Orders 25 More Vertex Mixed-reality Trainers Aviation International News

Vertex Energy files for bankruptcy, explores sale Reuters

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress Business Wire

Vectrus and Vertex to Combine, Creating a Global Leader in Mission-Essential Solutions PR Newswire

Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550 富途牛牛

New Painkiller Could Bring Relief to Millions—Without Addiction Risk Scientific American

The Drug Is a ‘Miracle’ but These Families Can’t Get It (Published 2023) The New York Times

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting Business Wire

Lonza, Vertex Break Ground on New US Cell Therapy Plant CHEManager

Vertex non-opioid painkiller meets main goal in late-stage trials Reuters

Vertex, CRISPR's gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia Fierce Pharma

Truist Financial Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Announces Target Price $472.27 富途牛牛

BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $530 富途牛牛

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics Fierce Pharma

Spongy Scalp Swelling in a Middle-Aged Female: A Case Report of Lipedematous Scalp Cureus

BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $557 富途牛牛

UBS Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Cuts Target Price to $582 富途牛牛

People With Severe Diabetes Are Cured in Small Trial of New Drug The New York Times

Trinasolar US displays 2000 V module, trackers, energy storage and more pv magazine USA

Vertex cystic fibrosis treatment gets U.S. nod for use in children aged 6-11 Reuters

Leidos, Paramount USA and Vertex Aerospace Enter Final Phase of Armed Overwatch Competition Paramount Group

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions Business Wire

Vertex Pharmaceuticals (NDQ:VRTX): Another >US$100bn biotech that is facing the cliff like its peers, but might be safer Stocks Down Under

Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control Business Wire

How Vertex Ventures US uses PitchBook to size up startups and their competitors | PitchBook PitchBook

Vertex wins US Navy logistics support contract for AHTS programme Naval Technology

Leidos, Paramount USA, and Vertex Aerospace Team Up to Pursue U.S. Special Operations Command Armed Overwatch Prototype Program Paramount Group

A Cost-Utility Analysis Of Vertex's CF Drugs — What It Teaches Us About Trial Design Clinical Leader

3D Systems CEO Tells Us About the Acquisition of Vertex Dental and NextDent, Taking a Big Step into the Dental 3D Printing Market 3DPrint.com

Liberty Walk Still Smitten With The Ferrari 360 Modena Carscoops

Exxon, Parexel, RadioShack, VeriFone, Vertex: U.S. Equity Movers Bloomberg.com